LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset (ID:20238)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | PHA-793887 | 0.04 | uM | LJP6 | 3 | E24 | 72 | hr | 765 | 1599 | 3124 | 0.5118 | 0.3535 |
MCF 10A | Afatinib | 1.11 | uM | LJP6 | 2 | G21 | 72 | hr | 1694 | 1785 | 11155 | 0.1600 | 0.0096 |
MDA-MB-231 | Sirolimus | 0.37 | uM | LJP6 | 1 | L16 | 72 | hr | 1311 | 4414 | 5013 | 0.8804 | 0.8381 |
MDA-MB-231 | Sorafenib | 0.37 | uM | LJP6 | 2 | B10 | 72 | hr | 1311 | 5207 | 5013 | 1.0386 | 1.0523 |
MDA-MB-231 | Torin1 | 0.37 | uM | LJP6 | 3 | O16 | 72 | hr | 1311 | 2135 | 5013 | 0.4259 | 0.2224 |
MDA-MB-231 | Torin1 | 0.37 | uM | LJP6 | 1 | O16 | 72 | hr | 1311 | 1919 | 5013 | 0.3828 | 0.1641 |
MDA-MB-231 | Torin1 | 0.37 | uM | LJP6 | 2 | O16 | 72 | hr | 1311 | 1900 | 5013 | 0.3790 | 0.1589 |
MDA-MB-231 | BMS345541 | 1.11 | uM | LJP6 | 3 | D03 | 72 | hr | 1311 | 3823 | 5013 | 0.7625 | 0.6784 |
MDA-MB-231 | Alvocidib | 1.11 | uM | LJP6 | 2 | A15 | 72 | hr | 1311 | 773 | 5013 | 0.1542 | -0.1455 |
MDA-MB-231 | XMD11-50 | 0.37 | uM | LJP6 | 2 | P10 | 72 | hr | 1311 | 3409 | 5013 | 0.6800 | 0.5666 |
MDA-MB-231 | Withaferin A | 0.37 | uM | LJP6 | 3 | G16 | 72 | hr | 1311 | 3521 | 5013 | 0.7023 | 0.5968 |
MDA-MB-231 | XMD11-50 | 0.37 | uM | LJP6 | 1 | P10 | 72 | hr | 1311 | 3686 | 5013 | 0.7352 | 0.6414 |
MDA-MB-231 | Alvocidib | 1.11 | uM | LJP6 | 1 | A15 | 72 | hr | 1311 | 765 | 5013 | 0.1526 | -0.1477 |
MDA-MB-231 | ZSTK474 | 0.37 | uM | LJP6 | 2 | M16 | 72 | hr | 1311 | 3376 | 5013 | 0.6734 | 0.5576 |
MDA-MB-231 | Afatinib | 1.11 | uM | LJP6 | 3 | G21 | 72 | hr | 1311 | 3493 | 5013 | 0.6967 | 0.5893 |
MDA-MB-231 | BMS345541 | 1.11 | uM | LJP6 | 2 | D03 | 72 | hr | 1311 | 3700 | 5013 | 0.7380 | 0.6452 |
MDA-MB-231 | AZD 5438 | 1.11 | uM | LJP6 | 1 | J03 | 72 | hr | 1311 | 1210 | 5013 | 0.2414 | -0.0275 |
MDA-MB-231 | AT-7519 | 1.11 | uM | LJP6 | 1 | K03 | 72 | hr | 1311 | 787 | 5013 | 0.1570 | -0.1418 |
MDA-MB-231 | AT-7519 | 1.11 | uM | LJP6 | 3 | K03 | 72 | hr | 1311 | 761 | 5013 | 0.1518 | -0.1488 |
MDA-MB-231 | BMS345541 | 1.11 | uM | LJP6 | 1 | D03 | 72 | hr | 1311 | 3861 | 5013 | 0.7701 | 0.6887 |
MDA-MB-231 | AZD7762 | 1.11 | uM | LJP6 | 2 | L03 | 72 | hr | 1311 | 1205 | 5013 | 0.2404 | -0.0288 |
MDA-MB-231 | BI-2536 | 1.11 | uM | LJP6 | 3 | D15 | 72 | hr | 1311 | 1221 | 5013 | 0.2435 | -0.0245 |